Validity of Random Triglyceride Levels in Infants Receiving Parenteral Nutrition
Affiliation
Department of Pediatrics, University of Arizona Health SciencesBanner University Medical Center
College of Pharmacy, University of Arizona
Department of Pediatrics, University of Arizona Health Sciences
Issue Date
2021Keywords
hypertriglyceridemiaintravenous fat emulsions
neonate
parenteral nutrition
triglyceride levels
Metadata
Show full item recordPublisher
Frontiers Media S.A.Citation
Bader, M. Y., Lam, M. A., Munoz, F., Thompson, L., & Kylat, R. I. (2021). Validity of Random Triglyceride Levels in Infants Receiving Parenteral Nutrition. Frontiers in Pediatrics, 9.Journal
Frontiers in PediatricsRights
Copyright © 2021 Bader, Lam, Munoz, Thompson and Kylat. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Background: Intravenous lipid emulsions (IL) are an important part of parenteral nutrition (PN) to meet essential fatty acid (EFA) requirements and metabolic demands of neonates and preterm infants. Some critically-ill neonates may not metabolize IL effectively which can lead to hypertriglyceridemia. Risks associated with this include increased pulmonary vascular resistance, displaced bilirubins, and platelet or macrophage dysfunction. Serum triglyceride (TG) concentration is used as a marker for lipid tolerance and predictor of potential complications involved with IL administration, but the clinical significance of this is still debated. Management of TG levels with regard to timing of laboratory tests, the ideal goal range, and duration of infusion of IL varies across institutions and is not standardized. Methods: Single-center, retrospective study of newborn infants receiving parenteral nutrition (PN). Fasting and non-fasting TG levels were drawn during the same lipid infusion of 2–3g/kg/day. The primary outcome was the difference between fasting and non-fasting TG levels. Statistical assessment of continuous data was done with student t-test and nominal data was evaluated using X2-test and logistic regression. Results: Forty infants were included with mean gestational age at birth of 29.5 ± 3.4 weeks and mean birth weight of 1.3 ± 0.5 kg. Mean time between lab draws while on same IL dose was 11.6 ± 0.2 h with resulting mean fasting and non-fasting (random) TG levels 82 ± 40 mg/dL (95% CI 68.4, 97.6) and 101 ± 40 mg/dL (95% CI 88.5, 115.8), respectively. Mean difference between TG levels during lipid-free interval and during infusion was −18.6 ± 51.2 mg/dL (95% CI −35.0, −2.3; p = 0.03). Conclusion: We concluded there is no difference in the management of IL, when TG level was drawn randomly or as fasting sample. Obtaining TG level during routine lab draws is appropriate. We extrapolated that the administration of IL over 24 h will not interfere with TG level. © Copyright © 2021 Bader, Lam, Munoz, Thompson and Kylat.Note
Open access journalISSN
2296-2360Version
Final published versionae974a485f413a2113503eed53cd6c53
10.3389/fped.2021.601915
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2021 Bader, Lam, Munoz, Thompson and Kylat. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).

